期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

来曲唑在绝经后乳腺癌新辅助内分泌治疗中的应用 被引量：8

下载PDF
导出
摘要 目的评价来曲唑在绝经后乳腺癌新辅助内分泌治疗中的应用价值。方法对110例绝经后乳腺癌患者进行来曲唑新辅助内分泌治疗,设置他莫西芬新辅助内分泌治疗为对照组。结果来曲唑组内分泌治疗前后乳腺癌临床分期方面有统计学差异(P<0.05);来曲唑组临床疗效明显优于他莫西芬组(P<0.05)。两组均未出现明显毒副反应。结论来曲唑新辅助内分泌治疗绝经后乳腺癌安全、有效,是优于他莫西芬的新辅助内分泌治疗方案。
作者 李荣萍 任佳 吕文静 张立娜 刘峰
机构地区 秦皇岛市第一医院 秦皇岛市肿瘤医院
出处 《山东医药》 CAS 北大核心 2009年第32期67-69,共3页 Shandong Medical Journal
关键词 乳腺肿瘤 辅助化疗 内分泌治疗 来曲唑
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献7

二级参考文献27

  • 1[1]Gale K E, Andersen J W, Tormey D C, et al. Hormonal treatment for metastatic breast cancer: An Eastern Cooperative Oncology Group phase Ⅲ trial comparing aminoglutethimide to tamoxifen [J]. Cancer, 1994,73:354-361
  • 2[2]Thuerlimann B, Beretta K, Bacchi M, et al. First line fadrozole HCL(CGS 16949A) versus tamoxifen in postmenopausal patients with advanced breast cancer [J]. Ann Onco1,1996,7:471-479
  • 3[3]Gershanovich M, Chaudri H A, Campos D, et al. Letrozole, a new aromatase inhibitor: Randomized trial comparing 0.5 mg and 2.5mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer [J]. Ann Onco1,1998,9:639-645
  • 4[4]Kaufmann M, Bajetta E, Dirix L Y, et al. Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase Ⅲrandomised double-blind trial [J]. J Clin Oncol,2000,18:1399-1411
  • 5[5]Mouridsen H, Gershanovich M, Sun Y, et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase Ⅲ study of the International Letrozole Cancer Group [J]. J Clin Oncol,2001,19:2596-2606
  • 6Ragini K, Rush M, O'Regan A. Aromatase inhibitors as adjuvant therapy for postmenopansal patients with early stage breast cancer[J].Cancer J Clin, 2005,55:145-163.
  • 7Brian J L, Danijela J, Venkatesh H,et al. Therapeutic s trategie susing the aromatase inhibitor retrozole and tamoxifen in a breastc ancer model[J]. J Natl Cancer Inst,2004,96:456-465.
  • 8Mouridsen H, Chaudri-Ross H A. Breast cancer efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer [J]. The Oncologist,2004,9:497-506.
  • 9Geisler J, Haynes B, Anker G, et al. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized,cross-over study[J]. J Clin Oncol,2002,20:751-757.
  • 10Moufidsen H, Gershanovich M, Sun Y, et al. Phase Ⅲ study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International letrozole Breast Cancer Group[J]. J Clinical Oncol,2003,21:2101-2109.

共引文献32

同被引文献106

  • 1陈伟财,何劲松,王敏,吴恢升,王先明.老年乳腺癌患者新辅助内分泌治疗的临床应用[J].中国癌症杂志,2011,21(5):359-362. 被引量：23
  • 2江泽飞,徐兵河,宋三泰,孙燕.乳腺癌内分泌治疗的基本共识[J].中华肿瘤杂志,2006,28(3):238-239. 被引量：48
  • 3张斌.乳腺癌新辅助内分泌治疗[J].中国癌症杂志,2006,16(9):689-692. 被引量：9
  • 4Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrativecases [ J ]. Lancet, 1896,2 : 104.
  • 5Jordan VC. Tamoxifen: a most unlikely pioneering medicine [ J ]. Nat Rev Drug Discov,2003,2 ( 3 ) :205.
  • 6Gradishar W J. Recently initiated studies: neoadjuvant treatments in next century [J]. Semi Oncol, 1999,26( 1 suppl 3 ) :26.
  • 7Miller WR, Dixon JM. Local endocrine effects of aromatase inhibitors within the berast [ J ]. J Steroid Biochem Mol Biol, 2001,79 ( 1 - 5 ) :93.
  • 8Tan SM, Cheung KL, Willsher PC, et al. Locally advanced primary breast cancer: medium - term results of arandomized trial of multimodal therapy versus initial hormone therapy[ J]. Eur J Cancer,2001,37 ( 18 ) :2331.
  • 9Manriac L, Debled M, Durand M, et al. Neoadjuvant tamoxifen for hormone - sensitive non - metastatic breast carcinoma in early postmenopausal women [ J ]. Ann Oncel,2002,13 ( 2 ) :293.
  • 10Dixon JM, Anderson TJ, Miller WR. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective [J]. Eur J Cancer,2002,38(17):2214.

引证文献8

二级引证文献53

山东医药
2009年 第32期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部